Trials / Completed
CompletedNCT00984529
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether treatment with candesartan cilexetil for at least 6 months in patients with chronic heart failure improves clinical signs and symptoms of chronic heart failure.
Conditions
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-02-01
- Completion
- 2010-02-01
- First posted
- 2009-09-25
- Last updated
- 2011-01-07
Locations
15 sites across 1 country: Croatia
Source: ClinicalTrials.gov record NCT00984529. Inclusion in this directory is not an endorsement.